Jump Financial’s Arcus Biosciences RCUS Stock Holding History

Jump Financial’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.26M	Buy	242,258 +160,222	+195%	+$4.52M	0.04%	516
2026 Q2	$2.53M	Sell	82,036 -53,764	-40%	-$1.33M	0.02%	795
2026 Q1	$2.93M	Buy	+135,800	New	+$2.93M	0.04%	516
2025 Q1	–	Sell	-17,244	Closed	-$257K	–	1947
2024 Q4	$257K	Buy	+17,244	New	+$282K	0.01%	1384
2024 Q2	–	Sell	-32,190	Closed	-$608K	–	2176
2024 Q1	$608K	Buy	+32,190	New	+$557K	0.02%	1066
2023 Q3	–	Sell	-63,921	Closed	-$1.3M	–	2175
2023 Q2	$1.3M	Buy	+63,921	New	+$1.22M	0.05%	554
2022 Q1	–	Sell	-9,783	Closed	-$396K	–	1847
2021 Q4	$396K	Buy	+9,783	New	+$379K	0.02%	763
2021 Q1	–	Sell	-17,359	Closed	-$451K	–	1223
2020 Q4	$451K	Sell	17,359 -2,776	-14%	-$67.2K	0.08%	413
2020 Q3	$345K	Buy	+20,135	New	+$450K	0.07%	449

Other funds holding RCUS

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jump Financial's RCUS Position: Q3 2026 in Review

Jump Financial increased its Arcus Biosciences (RCUS) stake by 195% in Q3 2026, buying an estimated $4.52M and bringing the position to 242,258 shares worth $6.26M. The position accounts for 0.04% of the portfolio, ranked #516.

Jump Financial first reported a position in RCUS in Q3 2020 and has held it in 9 quarters since. 171 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

Jump Financial held 242,258 shares of Arcus Biosciences worth $6.26M as of Q3 2026.
Jump Financial bought 160,222 Arcus Biosciences shares in Q3 2026, an estimated $4.52M.
Arcus Biosciences made up 0.04% of Jump Financial's portfolio in Q3 2026, its #516 holding.
Jump Financial first reported a position in Arcus Biosciences in Q3 2020 and has held it in 9 quarters since.
171 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.